Vineet Laboratories (Small Cap) Share Target 2025, 2026 To 2035
|
Vineet Laboratories Limited |
|||
|
Price: ₹38.91 (-3.69%) | ||
| 52 Week Low: ₹38.20 52 Week High: ₹78.45 |
|||
| Market Capital: 49.18 Crore (Smallcap) | |||
| Basic Materials -> Chemicals | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Vineet Laboratories Share Price Target For 2025
- 1.1.1: Vineet Laboratories Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Vineet Laboratories Share Price Target For 2026
- 1.2.1: Vineet Laboratories Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Vineet Laboratories Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Vineet Laboratories Brief Company Overview
- 4: Vineet Laboratories Financial Performance
- 4.0.1: Is Vineet Laboratories A Good Buy For Long Term?
Vineet Laboratories, a Small Cap company in the Chemicals Industry with 1.6% profit margin.
To predict the Vineet Laboratories's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Vineet Laboratories Share Price Target For 2025
The line chart displays the monthly closing prices of Vineet Laboratories with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Vineet Laboratories shares in 2025, see the table below.
Vineet Laboratories Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 47.2 (+21.3%) | Price Action: 18 Mar 2024 Low |
| 2025 Target 2 | 46.6 (+19.76%) | Price Action: 15 Mar 2024 Low |
| 2025 Target 1 | 45.81 (+17.73%) | Price Action: 14 Feb 2025 High |
| Current Price | 38.91 | Vineet Laboratories's share price as of 25 Feb 2025 |
| Stop Loss 1 | 35.99 (-7.51%) | Price Action: Chart |
| Stop Loss 2 | 35.63 (-8.43%) | Price Action: Chart |
| Stop Loss 3 | 34.99 (-10.08%) | Price Action: Chart |
Short-Term Technical Outlook
Current Technical Position: Vineet Laboratories is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹47.04 serves as the nearest technical reference point.
Historical Returns: 3-month: -26.7% | 6-month: -34.14% | 1-year: -27.61%
Vineet Laboratories Share Price Target For 2026
The line chart displays the monthly closing prices of Vineet Laboratories with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Vineet Laboratories shares in 2026, see the table below.
Vineet Laboratories Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 70.95 (+82.34%) | Price Action: 16 Nov 2023 High |
| 2026 Target 2 | 70.12 (+80.2%) | Price Action: 31 Jul 2024 Low |
| 2026 Target 1 | 69.4 (+78.36%) | Price Action: 19 Dec 2023 High |
| Current Price | 38.91 | Vineet Laboratories's share price as of 25 Feb 2025 |
| Stop Loss 1 | 30.9 (-20.59%) | Price Action: Chart |
| Stop Loss 2 | 30.59 (-21.39%) | Price Action: Chart |
| Stop Loss 3 | 30.04 (-22.8%) | Price Action: Chart |
Long-Term Technical Outlook
52-Week Range Analysis: Vineet Laboratories is currently trading near its 52-week low of ₹38.2, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -27.61% | 3-year: -33.63% | 5-year: NA
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Vineet Laboratories Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹38.91 | ||
| 2025 | ₹55.72 | +43.2% | ₹56.56 |
| 2026 | ₹55.73 | +0.01% | ₹56.57 |
| 2027 | ₹52.75 | -5.34% | ₹53.54 |
| 2028 | ₹52.17 | -1.09% | ₹52.95 |
| 2029 | ₹48.88 | -6.3% | ₹49.61 |
| 2030 | ₹47.62 | -2.57% | ₹48.33 |
| 2031 | ₹44.92 | -5.66% | ₹45.59 |
| 2032 | ₹45.46 | +1.2% | ₹46.14 |
| 2033 | ₹41.64 | -8.4% | ₹42.26 |
| 2034 | ₹42.79 | +2.76% | ₹43.43 |
| 2035 | ₹42.77 | -0.04% | ₹43.41 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Vineet Laboratories Brief Company Overview
Vineet Laboratories Limited: A Leading Player in Pharmaceutical Ingredients and Fine Chemicals Vineet Laboratories Limited is a reputable Indian company engaged in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and fine...
chemicals. Incorporated in 2016 and headquartered in Hyderabad, India, the company has quickly established a strong presence in the industry. Key Products and Diverse Range: API intermediates for lopinavir, ritonavir, efavirenz, and other drugs Fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside and 3-bromofuran Commitment to Innovation: Vineet Laboratories Limited is committed to continuous research and development to expand its product range and meet evolving market needs.Vineet Laboratories Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 49.18 Crore | Market valuation of Vineet Laboratories's shares. |
| Revenue (TTM) | 170.74 Crore | Total revenue generated by Vineet Laboratories over the past twelve months. |
| Net Income (TTM) | +2.65 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -3.89% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +1.55% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-51.1% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
116.54 | Company's total debt divided by total shareholder equity. |
| Total Debt | 40.61 Crore | Sum of Vineet Laboratories's current & long-term financial obligations. |
| Total Cash | 1.1 Crore | Total amount of liquid funds available to Vineet Laboratories. |
| Beta | -0.3 | Beta is less than 1 indicating that the Vineet Laboratories's price is less volatile than the market. |
Is Vineet Laboratories A Good Buy For Long Term?
Vineet Laboratories is a small-cap stock with a market capitalization of Rs. 49.18 crore. It has shown a decline in revenue of 51.1% compared to the previous quarter. Its profit margin is 1.55%. The company has a debt of Rs. 40.61 crore. Overall, Vineet Laboratories may not be a good buy for long-term investment due to its poor financial performance and high debt levels.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
